MAPI Group Appoints James M. Karis as Chief Executive Officer

LYON, France, January 7, 2013 /PRNewswire/ --

The Healthcare services group MAPI has named James M. Karis its Chief Executive Officer. MAPI, a pioneer in Patient Assessment, Late Phase Studies, PharmacoEpidemiology, PharmacoEconomics, PRO Evidence, and Market Access, has experienced constant growth for almost four decades establishing a solid reputation in the Healthcare industry. MAPI looks to Mr. Karis to consolidate its success and further position the group as the most trusted source of insight in improving health decision making.

     (Photo: http://photos.prnewswire.com/prnh/20130107/586467 )

"James comes to MAPI with international experience and knowledge of the market place that will be extremely valuable in integrating our service offerings and bringing our customers better value in a changing market," said Bernard Jambon, Chairman of the MAPI Group. "Over the years, we have built solid expertise that makes us a trustworthy partner to the health industry throughout the lifecycle of their products. Our experience is unique and we need a proven leader to guide us into the future by setting the strategic vision and building the platform to support it - James is that person."

"I am excited to have this opportunity to step in at this time to help shape MAPI's growth and provide the strategic and operational platform to fuel its expansion," said James Karis. "In a worldwide healthcare industry and regulatory environment that is becoming more patient-centric while requiring improved effectiveness and greater value, MAPI holds a unique position to provide the needed strategic insight and service leadership to its customers and partners. I look forward to building a solid organization and setting a strategy that can support the Company's growth and expansion."

Mr. Karis, formerly CEO of CollabRx Inc., CEO of Entelos and COO of Parexel and an advisor and independent member for Life Science and Healthcare companies, comes with over 30 years of experience in the pharmaceutical, healthcare services, technology and medical device industries.

Bernard Jambon

Chairman, MAPI Group

About MAPI:

MAPI is a leading global organization, offering evaluation and support of therapeutic strategies. With offices worldwide, MAPI provides high quality and efficient operations to help our clients secure product approvals and reimbursement, as well as addressing post-marketing requirements and late phase needs, meeting the needs of patients, physicians, regulatory authorities and health care technology purchasers. For more information about MAPI, visit: http://wwwmapigroup.com/

SOURCE MAPI Group